11![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. ® HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. ®](https://www.pdfsearch.io/img/3aea3d5c7ede2598667e37a90af79eb7.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2014-11-07 17:30:30
|
---|
12![Patient Information NuvaRing® (NEW-vah-ring) (etonogestrel/ethinyl estradiol vaginal ring) What is the most important information I should know about NuvaRing? Patient Information NuvaRing® (NEW-vah-ring) (etonogestrel/ethinyl estradiol vaginal ring) What is the most important information I should know about NuvaRing?](https://www.pdfsearch.io/img/8158629a2b36fc0fbd1ad4d59bcfc2fc.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2014-11-07 17:30:31
|
---|
13![Contraceptive Implant Approved by FDA September 2006 Women in the US will soon have another contraceptive method available to them. The Food and Drug Administration has approved Implanon, a contraceptive implant. It’s Contraceptive Implant Approved by FDA September 2006 Women in the US will soon have another contraceptive method available to them. The Food and Drug Administration has approved Implanon, a contraceptive implant. It’s](https://www.pdfsearch.io/img/179ba3de83ed182068cf496a389355a3.jpg) | Add to Reading ListSource URL: www.idahoperinatal.orgLanguage: English - Date: 2010-08-10 15:26:15
|
---|
14![MIRCETTE® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets[removed] MIRCETTE® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets[removed]](https://www.pdfsearch.io/img/922608ec56b43579b89190ce8a9c888d.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-07-19 14:15:07
|
---|
15![Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Marvelon Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Marvelon](https://www.pdfsearch.io/img/faba8f55db3fde97841690e911428f6c.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2012-03-07 11:19:28
|
---|
16![Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Cerazette (Desogestrel) Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Cerazette (Desogestrel)](https://www.pdfsearch.io/img/e236a5bea079789b57ab2480ce9dde08.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2012-03-07 11:19:27
|
---|
17![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing information for NEXPLANON. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing information for NEXPLANON. •](https://www.pdfsearch.io/img/dffad204594729e36b9a8eaf0b58290c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2011-06-01 14:34:51
|
---|
18![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl est HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl est](https://www.pdfsearch.io/img/34af360d09e93ef371f1801116746960.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-06-23 15:51:16
|
---|